AI in clinical trials holds great promise for the entire drug development lifecycle. However, any new technology should ...
A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...
The statistical methods scientists use to analyze outcomes from clinical trials in amyotrophic lateral sclerosis (ALS) vary widely, and these differences may make some trials prone to generating ...
Applied Biologics, a biopharmaceutical company advancing novel biologic therapies for chronic wounds, tissue repair, and degenerative disease, presented interim clinical data from the CAMPX Trial at ...
Identifying Health Information Technology Needs of Oncologists to Facilitate the Adoption of Genomic Medicine: Recommendations From the 2016 American Society of Clinical Oncology Omics and Precision ...
Industry groups have asked the US Food and Drug Administration (FDA) to provide more clarity about its regulatory approach to ...
AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today reported positive progress in a mid-year update from the ongoing Phase 2 clinical study evaluating AIM’s drug Ampligen ® ...
I think probably the best one is the urban patient who has access to an academic medical center that is running clinical ...
Clinical trial names span a broad range, from straightforward acronyms to more inspiring titles—see: Eli Lilly’s optimistically dubbed family of Triumph trials—to the downright ostentatious, like ...
7d
GOP bill would use opioid funds to jump-start clinical trials on psychedelic-based trauma treatment
Can a psychedelic drug with heavy side-effects and anecdotal evidence as a treatment for addiction become a wonder drug for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results